Figure 7.
Interference with RPS6 can inhibit the proliferation of PASMCs caused by hypoxia
(A) MTT assay in hypoxic and control PASMCs transfected with si-RPS6 or si-NC. (B) BrdU incorporation assay in hypoxic and control PASMCs transfected with si-RPS6 or si-NC. (C) WB analysis of PCNA in hypoxic and control PASMCs transfected with si-RPS6 or si-NC. (D) IF of Ki67 (scale bar, 10 μm) in hypoxic and control PASMCs transfected with si-RPS6 or si-NC. (E) WB analysis of cyclin A, cyclin D, cyclin E, CDK1, CDK2, and CDK4 in hypoxic and control PASMCs transfected with si-RPS6 or si-NC. All values are represented as the mean ± SEM (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001; n ≥ 3).